Arcellx Acquired by Gilead Sciences | Healthcare M&A Deal

Gilead Sciences has acquired Arcellx, a healthcare services other business in California, for $115.00. Arcellx is a healthcare company focused on developing and commercializing therapies, supporting Gilead Sciences acquisitions in healthcare M&A. Gilead Sciences acquisitions in CA acquisitions expand strategic acquisition capabilities across healthcare services other, strengthening merger acquisition efforts in the U.S. healthcare market. The Arcellx acquisition is a strategic acquisition and merger acquisition announced deal valued over $100M, with Gilead Sciences acquisitions positioned as a strategic acquisition to broaden its pipeline and product portfolio.